Institutions Holding Call Options on Moon Lake Immunotherapeutics (MLTX)
This table provides information about the call option holders of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the institutions that hold call options on the stock, with a total of 798,900 call options outstanding, which have been reported (via 13F filing form) to have a value of $44.2 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Caption Management, LLC
Oklahoma City, OK |
Aug 14, 2025 Q2 2025 |
295,700
calls
|
$16.4 Million
0.17% of portfolio
|
N/A
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 14, 2025 Q2 2025 |
131,000
calls
|
$7.25 Million
0.0% of portfolio
|
N/A
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Aug 14, 2025 Q2 2025 |
125,000
calls
|
$6.92 Million
1.62% of portfolio
|
Q2 2025
New holding
|
|
Ikarian Capital, LLC
Dallas, TX |
Aug 14, 2025 Q2 2025 |
94,500
calls
|
$5.23 Million
1.36% of portfolio
|
N/A
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
75,100
calls
|
$4.16 Million
0.0% of portfolio
|
N/A
|
|
Boothbay Fund Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
28,500
calls
|
$1.58 Million
0.03% of portfolio
|
N/A
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
26,600
calls
|
$1.47 Million
0.0% of portfolio
|
N/A
|
|
J. Goldman & CO LP
New York, NY |
Aug 14, 2025 Q2 2025 |
10,000
calls
|
$553,600
0.01% of portfolio
|
Q2 2025
Reduced 50.0%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
10,000
calls
|
$553,600
0.0% of portfolio
|
Q2 2025
New holding
|
|
Cutler Group LP
|
Apr 19, 2024 Q1 2024 |
2,500
calls
|
$138,400
0.0% of portfolio
|
N/A
|